How have GNOM shares performed in 2024?

Global X Genomics & Biotechnology ETF's stock was trading at $11.56 at the start of the year. Since then, GNOM stock has decreased by 15.4% and is now trading at $9.78. View the best growth stocks for 2024 here .

What does GNOM invest in?

Global X Genomics & Biotechnology ETF is a equity fund issued by Global X. GNOM focuses on theme investments and follows the Solactive Genomics Index. The fund's investments total to approximately $90.14 million assets under management.

What stocks does Global X Genomics & Biotechnology ETF hold?

GNOM invests in 44 holdings. Some of the stocks in their portfolio include CRISPR Therapeutics (CRSP) , Veracyte (VCYT) , Qiagen (QGEN) , Ultragenyx Pharmaceutical (RARE) , BioMarin Pharmaceutical (BMRN) , BioNTech (BNTX) , Alnylam Pharmaceuticals (ALNY) , Natera (NTRA) , Agilent Technologies (A) and Rocket Pharmaceuticals (RCKT) .

What is the management fee for Global X Genomics & Biotechnology ETF?

Global X Genomics & Biotechnology ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for GNOM is 0.50%.

What other stocks do shareholders of Global X Genomics & Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global X Genomics & Biotechnology ETF investors own include Inovio Pharmaceuticals (INO) , Gilead Sciences (GILD) , Intel (INTC) , Pfizer (PFE) , Quest Diagnostics (DGX) , Micron Technology (MU) , Dynavax Technologies (DVAX) , Matinas BioPharma (MTNB) .

How do I buy shares of Global X Genomics & Biotechnology ETF?

Shares of GNOM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:GNOM

Global X Genomics & Biotechnology ETF (GNOM) Price, Holdings, & News

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free GNOM Stock Alerts

$9.78

-0.11 (-1.11%)

(As of 04/18/2024 ET)

Compare

Today's Range: $9.76
▼
$9.90
50-Day Range: $9.78
▼
$12.29
52-Week Range: $8.63
▼
$13.33

Volume: 26,354 shs
Average Volume: 68,631 shs
Market Capitalization: $89.20 million

Assets Under Management: $90.14 million
Dividend Yield: 0.00%
Net Expense Ratio: 0.50%

Get Global X Genomics & Biotechnology ETF alerts:

About Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)

Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.

GNOM Stock Price History

30 days | 90 days | 365 days | Advanced Chart

GNOM ETF News Headlines

April 18, 2024 | markets.businessinsider.com

The Analyst Landscape: 4 Takes On 10x Genomics

March 21, 2024 | investorplace.com

3 Stocks That Could Be the Next Big Thing in Gene Editing

April 18, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

March 14, 2024 | finance.yahoo.com

Global X Genomics & Biotechnology UCITS ETF (GNOG.L)

March 6, 2024 | investing.com

Global X Genomics & Biotechnology ETF (GNOM)

December 29, 2023 | msn.com

Global X Cannabis ETF declares $0.1656 dividend

May 12, 2023 | investing.com

Global X S&P 500® Catholic Values ETF (CATH)

April 29, 2023 | benzinga.com

Global X Genomics & Biotechnology ETF (NASDAQ:GNOM), Quotes and News Summary

April 18, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

April 15, 2023 | thestreet.com

Complete Genomics Stock Falls On Unusually High Volume (GNOM)

See More Headlines

Receive GNOM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: Global X
Fund Name: Global X Genomics & Biotechnology ETF
Tax Classification: Regulated Investment Company
Stock Exchange: NASDAQ
Current Symbol: NASDAQ:GNOM
Inception Date: 4/5/2019
Fund Manager: Chang Kim, James Ong, Nam To, Wayne Xie
Web: www.completegenomics.com
Phone: +1-650-9432800

Fund Focus

Asset Class: Equity
Benchmark: Solactive Genomics Index
Category: Strategy
Focus: Theme
Development Level: Blended Development
Region: Global
Number of Holdings: 44

Fund Statistics

Assets Under Management: $90.14 million
Average Daily Volume: $0.00
Discount/Premium: 0.01%

Administrator, Advisor and Custodian

Administrator: Global X Management Company LLC
Advisor: Global X Management Company LLC
Custodian: Brown Brothers Harriman & Co.
Distributor: SEI Investments Distribution Co.
Transfer Agent: Brown Brothers Harriman & Co.
Trustee: N/A
Lead Market Maker: Susquehanna

Options

Optionable: N/A
Short Interest: 11,000 shs

Miscellaneous

Outstanding Shares: 9,120,000
Beta: 1.03
Creation Unit: 50,000
Creation Fee: $500.00

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

Global X Genomics & Biotechnology ETF Expenses

Type	GNOM	Theme ETFs	Equity ETFs	NASDAQ ETFs	All ETFs
Management Fee	0.50%	0.57%	0.54%	0.48%	0.51%
Other Expenses	0.00%	0.72%	0.54%	0.34%	0.58%
Total Expense	0.50%	0.72%	0.70%	0.58%	0.70%
Fee Waiver	0.00%	-0.76%	-0.55%	-0.22%	-0.57%
Net Expense	0.50%	0.59%	0.60%	0.54%	0.58%

Global X Genomics & Biotechnology ETF (GNOM) Holdings & Exposure

Top 10 GNOM Holdings

GNOM Sector Exposure

GNOM Industry Exposure

Full Holdings Details

Similar ETFs

Institutional Ownership

View All Institutional Transactions

GNOM ETF - Frequently Asked Questions

How have GNOM shares performed in 2024?: Global X Genomics & Biotechnology ETF's stock was trading at $11.56 at the start of the year. Since then, GNOM stock has decreased by 15.4% and is now trading at $9.78.
View the best growth stocks for 2024 here.
What does GNOM invest in?: Global X Genomics & Biotechnology ETF is a equity fund issued by Global X. GNOM focuses on theme investments and follows the Solactive Genomics Index. The fund's investments total to approximately $90.14 million assets under management.
What stocks does Global X Genomics & Biotechnology ETF hold?: GNOM invests in 44 holdings. Some of the stocks in their portfolio include CRISPR Therapeutics (CRSP), Veracyte (VCYT), Qiagen (QGEN), Ultragenyx Pharmaceutical (RARE), BioMarin Pharmaceutical (BMRN), BioNTech (BNTX), Alnylam Pharmaceuticals (ALNY), Natera (NTRA), Agilent Technologies (A) and Rocket Pharmaceuticals (RCKT).
What is the management fee for Global X Genomics & Biotechnology ETF?: Global X Genomics & Biotechnology ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for GNOM is 0.50%.

What other stocks do shareholders of Global X Genomics & Biotechnology ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Global X Genomics & Biotechnology ETF investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Intel (INTC), Pfizer (PFE), Quest Diagnostics (DGX), Micron Technology (MU), Dynavax Technologies (DVAX), Matinas BioPharma (MTNB).
How do I buy shares of Global X Genomics & Biotechnology ETF?: Shares of GNOM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GNOM) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial